Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis
Authors:
Open Access
- 23 January 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 159, 114255
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute (BX002761)
- National Cancer Institute (DK124095)
This publication has 40 references indexed in Scilit:
- Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinomaCancer, 2010
- Claudin Family of Proteins and Cancer: An OverviewJournal of Oncology, 2010
- Claudin-1 Acts through c-Abl-Protein Kinase Cδ (PKCδ) Signaling and Has a Causal Role in the Acquisition of Invasive Capacity in Human Liver CellsJournal of Biological Chemistry, 2010
- The claudinsGenome Biology, 2009
- Determination of microsome and hepatocyte scaling factors forin vitro/in vivoextrapolation in the rat and dogXenobiotica, 2008
- Is Src the key to understanding metastasis and developing new treatments for colon cancer?Nature Clinical Practice Gastroenterology & Hepatology, 2008
- Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motilityOncogene, 2006
- Claudin-1 regulates cellular transformation and metastatic behavior in colon cancerJournal of Clinical Investigation, 2005
- Prediction of post‐translational glycosylation and phosphorylation of proteins from the amino acid sequenceProteomics, 2004
- Disruption of epithelial cell-matrix interactions induces apoptosisJournal of Cell Biology, 1994